MedTrace Logo

Magnesium Sulfate Effects on Onset and Duration of Low Dose Rocuronium in Patients Undergoing Laparoscopic Cholecystectomy

NCT02669368 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2016-02-01

No results posted yet for this study

Summary

This study aims to evaluate effects of magnesium sulfate on onset and duration of low dose rocuronium, intubation condition and surgical condition in patients undergoing laparoscopic cholecystectomy.

Conditions

  • Muscle Relaxation

Interventions

DRUG

Magnesium Sulfate

Patients in each group receive Magnesium sulfate 30 mg/kg in 0.9% normal saline (total volume 100 ml) intravenously for 5 min before induction of anesthesia

DRUG

Saline

Patients in each group receive 0.9% normal saline (total volume 100 ml) alone intravenously for 5 min before induction of anesthesia

DRUG

Standard dose Rocuronium

0.6 mg/kg of Rocuronium given with induction of anesthesia

DRUG

Low dose Rocuronium

0.45 mg/kg of Rocuronium given with induction of anesthesia

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Nawal Abdelaziz Gadelrab, Professor · Assiut University

  • Ola Mahmoud Wahba, Lecturer · Assiut University Hospitals

  • Ahmed Hamada Hamed Amin, Resident · Assiut University Hospitals

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2016-03-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02669368 on ClinicalTrials.gov